Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 87: 574-581, 1999;
8750-7587/99 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Symons, J. D.
Right arrow Articles by Musch, T. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Symons, J. D.
Right arrow Articles by Musch, T. I.
Vol. 87, Issue 2, 574-581, August 1999

Interactions between angiotensin II and nitric oxide during exercise in normal and heart failure rats

J. David Symons1, Charles L. Stebbins1, and Timothy I. Musch2

1 Division of Cardiovascular Medicine, Department of Internal Medicine, University of California, Davis, California 95616; and 2 Departments of Kinesiology and of Anatomy and Physiology, Kansas State University, Manhattan, Kansas 66506

We hypothesized that nitric oxide (NO) opposes ANG II-induced increases in arterial pressure and reductions in renal, splanchnic, and skeletal muscle vascular conductance during dynamic exercise in normal and heart failure rats. Regional blood flow and vascular conductance were measured during treadmill running before (unblocked exercise) and after 1) ANG II AT1-receptor blockade (losartan, 20 mg/kg ia), 2) NO synthase (NOS) inhibition [NG-nitro-L-arginine methyl ester (L-NAME); 10 mg/kg ia], or 3) ANG II AT1-receptor blockade + NOS inhibition (combined blockade). Renal conductance during unblocked exercise (4.79 ± 0.31 ml · 100 g-1 · min-1 · mmHg-1) was increased after ANG II AT1-receptor blockade (6.53 ± 0.51 ml · 100 g-1 · min-1 · mmHg-1) and decreased by NOS inhibition (2.12 ± 0.20 ml · 100 g-1 · min-1 · mmHg-1) and combined inhibition (3.96 ± 0.57 ml · 100 g-1 · min-1 · mmHg-1;all P < 0.05 vs. unblocked). In heart failure rats, renal conductance during unblocked exercise (5.50 ± 0.66 ml · 100 g-1 · min-1 · mmHg-1) was increased by ANG II AT1-receptor blockade (8.48 ± 0.83 ml · 100 g-1 · min-1 · mmHg-1) and decreased by NOS inhibition (2.68 ± 0.22 ml · 100 g-1 · min-1 · mmHg-1; both P < 0.05 vs. unblocked), but it was unaltered during combined inhibition (4.65 ± 0.51 ml · 100 g-1 · min-1 · mmHg-1). Because our findings during combined blockade could be predicted from the independent actions of NO and ANG II, no interaction was apparent between these two substances in control or heart failure animals. In skeletal muscle, L-NAME-induced reductions in conductance, compared with unblocked exercise (P < 0.05), were abolished during combined inhibition in heart failure but not in control rats. These observations suggest that ANG II causes vasoconstriction in skeletal muscle that is masked by NO-evoked dilation in animals with heart failure. Because reductions in vascular conductance between unblocked exercise and combined inhibition were less than would be predicted from the independent actions of NO and ANG II, an interaction exists between these two substances in heart failure rats. L-NAME-induced increases in arterial pressure during treadmill running were attenuated (P < 0.05) similarly in both groups by combined inhibition. These findings indicate that NO opposes ANG II-induced increases in arterial pressure and in renal and skeletal muscle resistance during dynamic exercise.

regional blood flow; vascular resistance; vascular conductance; NG-nitro-L-arginine methyl ester; losartan


This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation
Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. Carlstrom, J. D. Symons, T. C. Wu, R. S. Bruno, S. E. Litwin, and T. Jalili
A Quercetin Supplemented Diet Does Not Prevent Cardiovascular Complications in Spontaneously Hypertensive Rats
J. Nutr., March 1, 2007; 137(3): 628 - 633.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
T. A. McBride
AT1 receptors are necessary for eccentric training-induced hypertrophy and strength gains in rat skeletal muscle
Exp Physiol, March 1, 2006; 91(2): 413 - 421.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. D. Symons, J. C. Rutledge, U. Simonsen, and R. A. Pattathu
Vascular dysfunction produced by hyperhomocysteinemia is more severe in the presence of low folate
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H181 - H191.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. M. Karim, A. Y. Rhee, A. M. Given, M. D. Faulx, B. D. Hoit, and F. V. Brozovich
Vascular Reactivity in Heart Failure: Role of Myosin Light Chain Phosphatase
Circ. Res., September 17, 2004; 95(6): 612 - 618.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
P. McDonough, B. J. Behnke, T. I. Musch, and D. C. Poole
Effects of chronic heart failure in rats on the recovery of microvascular PO2 after contractions in muscles of opposing fibre type
Exp Physiol, July 1, 2004; 89(4): 473 - 485.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. D. Symons, Y. Hayashi, and J. L. Ensunsa
Improved coronary vascular function evoked by high-intensity treadmill training is maintained in arteries exposed to ischemia and reperfusion
J Appl Physiol, October 1, 2003; 95(4): 1638 - 1647.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
T. E. Richardson, C. A. Kindig, T. I. Musch, and D. C. Poole
Effects of chronic heart failure on skeletal muscle capillary hemodynamics at rest and during contractions
J Appl Physiol, September 1, 2003; 95(3): 1055 - 1062.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
T. P. Gavin, D. A. Spector, H. Wagner, E. C. Breen, and P. D. Wagner
Effect of captopril on skeletal muscle angiogenic growth factor responses to exercise
J Appl Physiol, May 1, 2000; 88(5): 1690 - 1697.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online